Personalized circulating tumor DNA analysis to detect residual disease after neoadjuvant therapy in breast cancer.
McDonald BR, Contente-Cuomo T, Sammut SJ, Odenheimer-Bergman A, Ernst B, Perdigones N, Chin SF, Farooq M, Mejia R, Cronin PA, Anderson KS, Kosiorek HE, Northfelt DW, McCullough AE, Patel BK, Weitzel JN, Slavin TP, Caldas C, Pockaj BA, Murtaza M.
McDonald BR, et al. Among authors: chin sf.
Sci Transl Med. 2019 Aug 7;11(504):eaax7392. doi: 10.1126/scitranslmed.aax7392.
Sci Transl Med. 2019.
PMID: 31391323
Free PMC article.